These constructs can provide a framework for the physician–patient discussion of choice and options regarding prostate cancer screening and help the patient to understand the relative contribution of each of these constructs to the ultimate choice of “Yes, you may benefit from being screened with the PSA” vs. “No, you may not benefit from being screened with the PSA.” The gene discussed is KLK3; the disease is Familial prostate cancer.